Literature DB >> 10802808

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies.

K Kanemaru1, N Kameda, H Yamanouchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802808     DOI: 10.1212/wnl.54.9.1875

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  32 in total

1.  Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer's disease.

Authors:  Kazutomi Kanemaru; Hiroshi Yamanouchi
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

2.  CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia.

Authors:  Francesca de Rino; Filippo Martinelli-Boneschi; Francesca Caso; Marta Zuffi; Matteo Zabeo; Gabriella Passerini; Giancarlo Comi; Giuseppe Magnani; Massimo Franceschi
Journal:  Neurol Sci       Date:  2011-11-29       Impact factor: 3.307

Review 3.  CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.

Authors:  Alessandro Stefani; Livia Brusa; Enrica Olivola; Mariangela Pierantozzi; Alessandro Martorana
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

4.  Recurrent spontaneous "neuroleptic malignant syndrome" in the absence of neuroleptic medication in probable dementia with Lewy bodies.

Authors:  K E Weber; R A Linker; R Lorenz; W Muellges; M Naumann; K Reiners; J Classen
Journal:  J Neurol       Date:  2005-03-14       Impact factor: 4.849

5.  Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification.

Authors:  Hidenaga Yamamori; Sabiha Khatoon; Inge Grundke-Iqbal; Kaj Blennow; Michael Ewers; Harald Hampel; Khalid Iqbal
Journal:  Neurosci Lett       Date:  2007-03-14       Impact factor: 3.046

Review 6.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

Review 7.  Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

Authors:  Anders Lönneborg
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 8.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

9.  Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia.

Authors:  Mirko Bibl; Hermann Esselmann; Piotr Lewczuk; Claudia Trenkwalder; Markus Otto; Johannes Kornhuber; Jens Wiltfang; Brit Mollenhauer
Journal:  Int J Alzheimers Dis       Date:  2010-08-24

10.  Genomic and Proteomic Biomarker Discovery in Neurological Disease.

Authors:  Rilee H Robeson; Andrew M Siegel; Travis Dunckley
Journal:  Biomark Insights       Date:  2008-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.